Who has invested in CytomX Therapeutics?

Fidelity Investments, Canaan Partners, Third Rock Ventures are named among the investors backing CytomX Therapeutics.

CytomX Therapeutics Funding: $136M Raised, IPO

CytomX Therapeutics funding overview

CytomX Therapeutics is a Biotech company based in San Francisco. CytomX Therapeutics has raised $136M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is an IPO. Investors on record include Fidelity Investments, Canaan Partners, Third Rock Ventures. 3 distinct backers are named across the disclosed rounds.

CytomX Therapeutics at a glance

Total raised: $136M
Latest round: IPO
Industry: Biotech
Headquarters: San Francisco
Notable investors: Fidelity Investments, Canaan Partners, Third Rock Ventures

Frequently asked about CytomX Therapeutics funding

How much has CytomX Therapeutics raised?: CytomX Therapeutics has raised $136M in total disclosed funding across the rounds on record.
Who has invested in CytomX Therapeutics?: Fidelity Investments, Canaan Partners, Third Rock Ventures are named among the investors backing CytomX Therapeutics.
What was the latest CytomX Therapeutics funding round?: The most recent disclosed round is an IPO.
Where is CytomX Therapeutics based?: CytomX Therapeutics is based in San Francisco.
What sector does CytomX Therapeutics operate in?: CytomX Therapeutics is tracked under Biotech from San Francisco, with $136M in disclosed funding.

Round data for CytomX Therapeutics is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the Biotech companies in San Francisco and backer lists below.

CytomX Therapeutics Funding: $136M Raised, IPO

CytomX Therapeutics funding overview

CytomX Therapeutics at a glance

Frequently asked about CytomX Therapeutics funding

CytomX Therapeutics founders (1)

Companies related to CytomX Therapeutics (40)

Browse related funding lists (7)